Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-019044
Filing Date
2021-04-15
Accepted
2021-04-15 17:17:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A etnb-defa14a_20210602.htm DEFA14A 29125
2 GRAPHIC gcr0i30z0buf000002.jpg GRAPHIC 67143
3 GRAPHIC gcr0i30z0buf000001.jpg GRAPHIC 105941
  Complete submission text file 0001564590-21-019044.txt   268716
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39122 | Film No.: 21829356
SIC: 2834 Pharmaceutical Preparations